Furthermore, it was suggested that RASAL1 functions in the progression of benign colonic neoplasms.[70] Therefore, in subjects who are at risk for CRC and bear benign polyps in their intestine containing mutated KRAS genes, upregulation of this gene could lead to progression to advanced malignant lesions. Here, KRAS is linked to colorectal carcinoma.